316 related articles for article (PubMed ID: 19552398)
1. HIV-1 peptide vaccine candidates: selecting constrained V3 peptides with highest affinity to antibody 447-52D.
Mester B; Manor R; Mor A; Arshava B; Rosen O; Ding FX; Naider F; Anglister J
Biochemistry; 2009 Aug; 48(33):7867-77. PubMed ID: 19552398
[TBL] [Abstract][Full Text] [Related]
2. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
[TBL] [Abstract][Full Text] [Related]
3. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
4. Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.
Mor A; Segal E; Mester B; Arshava B; Rosen O; Ding FX; Russo J; Dafni A; Schvartzman F; Scherf T; Naider F; Anglister J
Biochemistry; 2009 Apr; 48(15):3288-303. PubMed ID: 19281264
[TBL] [Abstract][Full Text] [Related]
5. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
6. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA
Structure; 2004 Feb; 12(2):193-204. PubMed ID: 14962380
[TBL] [Abstract][Full Text] [Related]
7. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
Zvi A; Feigelson DJ; Hayek Y; Anglister J
Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.
Sharon M; Görlach M; Levy R; Hayek Y; Anglister J
Protein Expr Purif; 2002 Apr; 24(3):374-83. PubMed ID: 11922753
[TBL] [Abstract][Full Text] [Related]
9. Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1.
Cruz LJ; Iglesias E; Aguilar JC; Cabrales A; Reyes O; Andreu D
Bioconjug Chem; 2004; 15(5):1110-7. PubMed ID: 15366967
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of the biologically active conformation of the principal neutralizing determinant of HIV-1(IIIB) containing a cis-proline surrogate: 1H NMR and molecular modeling study.
Garcia J; Dumy P; Rosen O; Anglister J
Biochemistry; 2006 Apr; 45(13):4284-94. PubMed ID: 16566603
[TBL] [Abstract][Full Text] [Related]
12. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
[TBL] [Abstract][Full Text] [Related]
13. Structural studies of human HIV-1 V3 antibodies.
Stanfield RL; Wilson IA
Hum Antibodies; 2005; 14(3-4):73-80. PubMed ID: 16720977
[TBL] [Abstract][Full Text] [Related]
14. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.
Gorny MK; VanCott TC; Hioe C; Israel ZR; Michael NL; Conley AJ; Williams C; Kessler JA; Chigurupati P; Burda S; Zolla-Pazner S
J Immunol; 1997 Nov; 159(10):5114-22. PubMed ID: 9366441
[TBL] [Abstract][Full Text] [Related]
16. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
[TBL] [Abstract][Full Text] [Related]
18. A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide.
Tugarinov V; Zvi A; Levy R; Anglister J
Nat Struct Biol; 1999 Apr; 6(4):331-5. PubMed ID: 10201400
[TBL] [Abstract][Full Text] [Related]
19. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
Tugarinov V; Zvi A; Levy R; Hayek Y; Matsushita S; Anglister J
Structure; 2000 Apr; 8(4):385-95. PubMed ID: 10801487
[TBL] [Abstract][Full Text] [Related]
20. The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.
Zolla-Pazner S; Zhong P; Revesz K; Volsky B; Williams C; Nyambi P; Gorny MK
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1254-8. PubMed ID: 15588347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
